GAIN THERAPEUTICS, INC Earnings Per Share, Basic and Diluted
GAIN THERAPEUTICS, INC (GANX) reported Earnings Per Share, Basic and Diluted of -$0.50 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-10.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-10
- GAIN THERAPEUTICS, INC earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.50.
- GAIN THERAPEUTICS, INC earnings per share, basic and diluted for the quarter ending 2020-03-31 was -$0.29.
| Period end | Earnings Per Share, Basic and Diluted 3 month |
|---|---|
| 2021-03-31 | -$0.50 10-Q · filed 2021-05-10 |
| 2020-03-31 | -$0.29 10-Q · filed 2021-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| Lexaria Bioscience Corp. (LEXX) | $0.084B | -1.92 | |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B |